MX357619B - Inhalador que comprende una composición que contiene tiotropio. - Google Patents

Inhalador que comprende una composición que contiene tiotropio.

Info

Publication number
MX357619B
MX357619B MX2014007358A MX2014007358A MX357619B MX 357619 B MX357619 B MX 357619B MX 2014007358 A MX2014007358 A MX 2014007358A MX 2014007358 A MX2014007358 A MX 2014007358A MX 357619 B MX357619 B MX 357619B
Authority
MX
Mexico
Prior art keywords
inhaler
tiotropium
composition
canister
inhalation
Prior art date
Application number
MX2014007358A
Other languages
English (en)
Other versions
MX2014007358A (es
Inventor
Zeng Xian-Ming
Fenlon Derek
Original Assignee
Teva Branded Pharmaceutical Products R&D Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45788842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX357619(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Branded Pharmaceutical Products R&D Inc filed Critical Teva Branded Pharmaceutical Products R&D Inc
Publication of MX2014007358A publication Critical patent/MX2014007358A/es
Publication of MX357619B publication Critical patent/MX357619B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04—Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0095—Preventing manual activation in absence of inhalation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Abstract

Esta invención se refiere a un inhalador dosificador, presurizado, que comprende un recipiente, en donde el recipiente contiene una formulación que comprende una sal de tiotropio y un propelente de HFA, en donde el inhalador es un inhalador accionado por la inhalación.
MX2014007358A 2011-12-19 2012-12-12 Inhalador que comprende una composición que contiene tiotropio. MX357619B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161577314P 2011-12-19 2011-12-19
GB201200504A GB201200504D0 (en) 2011-12-19 2012-01-13 An inhaler
PCT/EP2012/075230 WO2013092345A1 (en) 2011-12-19 2012-12-12 An inhaler comprising a tiotropium-containing-composition

Publications (2)

Publication Number Publication Date
MX2014007358A MX2014007358A (es) 2014-11-21
MX357619B true MX357619B (es) 2018-07-17

Family

ID=45788842

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007358A MX357619B (es) 2011-12-19 2012-12-12 Inhalador que comprende una composición que contiene tiotropio.

Country Status (22)

Country Link
US (1) US20140373832A1 (es)
EP (2) EP2606892B1 (es)
JP (1) JP2015502220A (es)
KR (2) KR20150118195A (es)
CN (1) CN104010640A (es)
AR (1) AR089597A1 (es)
AU (1) AU2012358128B2 (es)
BR (1) BR112014014536A2 (es)
CA (1) CA2856054C (es)
DK (2) DK2800567T3 (es)
EA (1) EA029047B1 (es)
ES (2) ES2644572T3 (es)
GB (1) GB201200504D0 (es)
HK (2) HK1200117A1 (es)
HU (2) HUE034667T2 (es)
IL (1) IL232945B (es)
MX (1) MX357619B (es)
PL (2) PL2800567T3 (es)
TW (1) TWI524905B (es)
UY (1) UY34526A (es)
WO (1) WO2013092345A1 (es)
ZA (1) ZA201403042B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
JP6335798B2 (ja) * 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
US9636425B2 (en) * 2012-09-18 2017-05-02 Focal Point Technologies, Llc Method of dry dye delivery for staining the eye
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
US20190054010A1 (en) * 2015-10-29 2019-02-21 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
US11083855B2 (en) 2015-12-21 2021-08-10 Kindeva Drug Delivery L.P. Auto-reset dose release firing systems, medicinal inhalers comprising same, and methods of using same
US11071837B2 (en) 2015-12-21 2021-07-27 Kindeva Drug Delivery L.P. Dose release firing systems and medicinal inhalers comprising same
GB2553535A (en) 2016-09-07 2018-03-14 3M Innovative Properties Co Trigger mechansim for an inhaler
GB2553534A (en) * 2016-09-07 2018-03-14 3M Innovative Properties Co Trigger mechanism for an inhaler
GB201702408D0 (en) 2017-02-14 2017-03-29 Norton (Waterford) Ltd Inhalers and related methods
GB201702407D0 (en) * 2017-02-14 2017-03-29 Norton (Waterford) Ltd Inhalers and related methods
WO2020006017A1 (en) * 2018-06-27 2020-01-02 3M Innovative Properties Company Tiotropium formulation and inhaler
FR3089127B1 (fr) * 2018-11-30 2020-11-20 Aptar France Sas Dispositif de distribution de produit fluide synchronisé avec l'inhalation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9026191D0 (en) 1990-12-01 1991-01-16 Harris Pharma Ltd Breath actuated dispensing device
GB2264238A (en) * 1992-05-29 1993-08-25 Norton Healthcare Ltd Medicament inhalor device
DE69324161T2 (de) 1992-12-09 1999-10-28 Boehringer Ingelheim Pharma Stabilisierte medizinische aerosollösungen
BR0015884A (pt) * 2000-05-22 2003-07-08 Chiesi Farma Spa Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
US6553988B1 (en) 2000-06-09 2003-04-29 Norton Healthcare, Inc. Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber
DE10214263A1 (de) 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
CN1726038A (zh) 2002-12-16 2006-01-25 贝林格尔英格海姆法玛两合公司 含有噻托铵的hfc溶液剂
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
EP2201934A1 (en) * 2008-12-23 2010-06-30 CHIESI FARMACEUTICI S.p.A. Tiotropium aerosol formulation products with improved chemical stability
DK2501363T3 (en) 2009-11-17 2015-03-23 Cipla Ltd inhalable

Also Published As

Publication number Publication date
EA029047B1 (ru) 2018-02-28
KR101629119B1 (ko) 2016-06-09
CA2856054A1 (en) 2013-06-27
EP2800567B1 (en) 2017-09-27
PL2606892T3 (pl) 2017-02-28
ZA201403042B (en) 2016-08-31
US20140373832A1 (en) 2014-12-25
GB201200504D0 (en) 2012-02-22
TW201341000A (zh) 2013-10-16
HUE034667T2 (en) 2018-02-28
JP2015502220A (ja) 2015-01-22
CN104010640A (zh) 2014-08-27
EP2606892A1 (en) 2013-06-26
CA2856054C (en) 2016-11-22
PL2800567T3 (pl) 2018-04-30
KR20150118195A (ko) 2015-10-21
UY34526A (es) 2014-07-31
NZ711668A (en) 2017-01-27
DK2800567T3 (da) 2017-11-06
HK1200117A1 (en) 2015-07-31
EP2800567A1 (en) 2014-11-12
IL232945A0 (en) 2014-07-31
ES2593281T3 (es) 2016-12-07
BR112014014536A2 (pt) 2017-06-13
IL232945B (en) 2018-05-31
NZ624160A (en) 2016-05-27
ES2644572T3 (es) 2017-11-29
EA201491205A1 (ru) 2014-10-30
WO2013092345A1 (en) 2013-06-27
DK2606892T3 (en) 2016-09-26
HUE030015T2 (en) 2017-04-28
AU2012358128B2 (en) 2015-09-17
MX2014007358A (es) 2014-11-21
TWI524905B (zh) 2016-03-11
HK1200341A1 (en) 2015-08-07
KR20140096159A (ko) 2014-08-04
AU2012358128A1 (en) 2014-05-22
EP2606892B1 (en) 2016-08-24
AR089597A1 (es) 2014-09-03

Similar Documents

Publication Publication Date Title
MX357619B (es) Inhalador que comprende una composición que contiene tiotropio.
HK1221920A1 (zh) 用於吸入器的劑量計數器
HK1218088A1 (zh) 包括分配劑和藥劑源的氣霧劑
PL2719416T3 (pl) Inhalator aerozolowy
EP2523716A4 (en) SINGLE DOSE INHALATION SYSTEMS WITHOUT PRESERVATION AGENT
EA201400591A1 (ru) Ингалятор
EP3113821A4 (fr) Masque facial pour inhalation, adapte a l'administration d'un gaz ou d'une molécule thérapeutique dans le cadre d'un traitement par inhalation, en particulier chez les enfants
HK1218712A1 (zh) 用於吸入施用的包含抗膽鹼能藥、皮質類固醇和β-腎上腺素能藥的干粉製劑
IL232762A0 (en) Aerosol device for inhalation of drugs that does not depend on the drug profile
EP2691135A4 (en) EXTENDER TUBE FOR AEROSOL DOSER
MY168300A (en) Pharmaceutical Composition for Inhalation
WO2012016845A3 (en) Pharmaceutical formulation comprising a phosphodiesterase inhibitor
GB2490770B (en) Drug delivery inhaler devices
TN2014000322A1 (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
EP2670461A4 (en) PATIENT-CONTROLLED ADMINISTRATION OF AEROSOLS
MX361925B (es) Medicamento inhalable que comprende tiotropio.
EP3016708A4 (en) Metered dose inhaler and methods thereof
PL2768561T3 (pl) Sposób produkcji aerozolowych zbiorników medycznych oraz dozownika zawierającego wspomniany zbiornik
EP3010832A4 (en) Valve for pressurized metered dose dispensers
WO2013166430A3 (en) Delivery of gaseous imaging contrast agent
WO2014177703A3 (de) Inhalator für ein dosieraerosol
GB201406875D0 (en) Metered dose inhaler canister and shroud
GB202003745D0 (en) Pressurised metered dose inhaler
EP3700515A4 (en) TIOTROPIUM INHALATION SOLUTION FOR NEBULIZATION
PT2617451T (pt) Conjunto para administrar um medicamento e inalador de dose única para a administração de um medicamento em pó que tenha esse conjunto

Legal Events

Date Code Title Description
FG Grant or registration